Allarity Therapeutics (ALLR) Change in Cash (2020 - 2026)

Allarity Therapeutics (ALLR) has 7 years of Change in Cash data on file, last reported at $15.2 million in Q1 2026.

• Quarterly Change in Cash rose 79.53% year-over-year to $15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 90.78% YoY) and the FY2025 annual result came in at -$4.2 million, down 121.84% from the prior year.
• Change in Cash climbed to $15.2 million in Q1 2026, from -$3.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $19.0 million in Q2 2024 to a low of -$8.0 million in Q2 2025.
• A 5-year average of $650470.6 and a median of -$1.1 million in 2025 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 1943.8% — and 2025, when it surged 44610.53%.
• Tracing ALLR's Change in Cash over 5 years: stood at -$1.5 million in 2022, then gained by 21.45% to -$1.2 million in 2023, then surged by 163.57% to $731000.0 in 2024, then tumbled by 577.56% to -$3.5 million in 2025, then soared by 534.92% to $15.2 million in 2026.
• The last three Change in Cash figures came in at $15.2 million (Q1 2026), -$3.5 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.